All In MedTech

Device Trial Radar · NCT05784558

RELIEF Study: Real-world Evaluation of LUTS Interventions and Patient Experience During Follow-up

Last checked: Nov 20, 2026Latest source record: Mar 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Jan 26, 2025

Primary completion

Jan 26, 2026

Study completion Sep 24, 2026

Sponsor

Lead sponsor
NeoTract, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 27, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
Male only, from 45 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the RELIEF Study is to compare the safety, effectiveness and patient experience outcomes in real-world subjects treated with different modalities for symptomatic BPH.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

  • UroLift SystemDevice

    The UroLift System is a procedure that utilizes tiny implants to lift and hold the enlarged prostate tissue out of the way so it no longer blocks the urethra.

  • Watchful Waiting or BPH MedicationsOther

    Subjects for whom the physician decides the best course of therapy to be either watchful waiting or new or continuing BPH medications.

  • Other Surgical InterventionDevice

    Physician decides the best course of therapy to be a surgical intervention other than the UroLift System.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To identify responders of IPSS changeTime frame: 3 months post-treatment visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Neotract Inc

    Pleasanton, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.